ACRS
Aclaris Therapeutics
Stock NASDAQ – Stock Market Prices, News & Analysis
Aclaris Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of treatments for dermatological diseases.
Aclaris Therapeutics
ACRS
Aclaris Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of treatments for dermatological diseases.
Price history of Aclaris Therapeutics
Price history of Aclaris Therapeutics
Performance & Momentum
Strategic Analysis
Aclaris Therapeutics • 2026
Aclaris Therapeutics is an American biopharmaceutical company specializing in the development of innovative treatments for dermatological diseases, positioned in a niche market with a high unmet medical need. Its model is based on the research and commercialization of targeted drugs, focusing on dermatological conditions that are often inadequately addressed by large pharmaceutical companies.
- In-depth expertise in dermatological diseases with a differentiated product pipeline
- Rapid growth potential linked to the specific and unmet needs of the dermatological market
- Ability to engage in strategic partnerships to accelerate development and commercialization
- History of volatile financial performance and significant long-term value loss
- Strong dependence on clinical results and regulatory approval that could impact valuation
Recent momentum is distinctly positive, reflecting a resurgence of investor interest likely supported by clinical or commercial advancements, which may provide an opportunity window to strengthen a position. However, the inherent volatility of the sector and the history of past performances warrant increased vigilance.
Similar stocks to Aclaris Therapeutics
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
